Solifenacin
Solifenacin is a pharmaceutical drug with 52 clinical trials. Currently 3 active trials ongoing. Historical success rate of 90.5%.
Success Metrics
Based on 38 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
3
Mid Stage
27
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
90.5%
38 of 42 finished
9.5%
4 ended early
3
trials recruiting
52
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in Females
Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)
Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)
Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrating Urinary Myelin Basic Protein as a Theranostic Biomarker
Clinical Trials (52)
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
Solifenacin Plus Tadalafil vs Solifenacin Alone for Overactive Bladder in Females
Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry)
Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)
Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrating Urinary Myelin Basic Protein as a Theranostic Biomarker
Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ.
Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.
Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania
Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease
Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin
Efficacy of Li-SWT on Persistent Storage Symptoms After Transurethral Surgery for BPO
Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes
Over Active Bladder Patients Having Sling Surgery
Electroacupuncture and Solifenacin for Urgency-predominant Mixed Urinary Incontinence
A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China
Incontinence & Intimate Partners: Assessing the Contribution of Treatment
Effect of Electroacupuncture Versus PFMT Plus Solifenacin for Mixed Urinary Incontinence
A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence
A Dose Titration Study of CPC-201 in Patients With Dementia of Alzheimer's Type
Pilot Trial Of Urinary Nerve Growth Factor (NGF) As Biomarker for Male Lower Urinary Tract Symptoms
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 52